Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Vehreschild

Showing results (191-200 of 221) with videos related to

Pageof 23
Sort By:
Nature Communications|June 12, 2026
Experimental human colonisation with non-toxigenic Clostridioides difficile: a placebo-controlled randomised clinical trialA D O Hensen, C Harmanus, P H Verbeek-Menken, et al.
Journal of Infection and Public Health|March 8, 2024
Prevalence of infectious diseases, immunity to vaccine-preventable diseases and chronic medical conditions among Ukrainian refugees in Germany - A cross sectional study from the German Network University Medicine (NUM)Folke Brinkmann, Anette Friedrichs, Georg Mn Behrens, et al.
Mayo Clinic Proceedings|March 18, 2026
Impact of COVID-19 vaccination on post-COVID syndrome across clinical definitions and phenotypes: a prospective multicenter cohort studyTanja Kraus, Hendrik Napierala, Anne Schrimpf, et al.
Critical Reviews in Microbiology|January 11, 2019
Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope<sup>®</sup>Danila Seidel, Arne Meißner, Michaela Lackner, et al.
International Journal of Antimicrobial Agents|December 20, 2016
Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA StudyPhilipp Koehler, Axel Hamprecht, Oliver Bader, et al.
Infection|July 31, 2025
Performance of whole blood interferon-γ release assays in SARS-CoV-2 and tuberculosis is age dependentTobias Rothoeft, Anna Teresa Hoffmann, Christoph Maier, et al.
European Journal of Neurology|August 19, 2021
Neurological symptoms and complications in predominantly hospitalized COVID-19 patients: Results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS)Nina N Kleineberg, Samuel Knauss, Eileen Gülke, et al.
Eclinicalmedicine|September 1, 2023
Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trialFlorent Malard, Michael Loschi, Anne Huynh, et al.
Frontiers in Medicine|July 3, 2023
Fighting Post-COVID and ME/CFS - development of curative therapiesCarmen Scheibenbogen, Judith Theresia Bellmann-Strobl, Cornelia Heindrich, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2019
Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn)Jon Salmanton-García, Danila Seidel, Philipp Koehler, et al.
Pageof 23

Showing results (191-200 of 221) with videos related to

Sort By:
Pageof 23
Nature Communications|June 12, 2026
Experimental human colonisation with non-toxigenic Clostridioides difficile: a placebo-controlled randomised clinical trialA D O Hensen, C Harmanus, P H Verbeek-Menken, et al.
Journal of Infection and Public Health|March 8, 2024
Prevalence of infectious diseases, immunity to vaccine-preventable diseases and chronic medical conditions among Ukrainian refugees in Germany - A cross sectional study from the German Network University Medicine (NUM)Folke Brinkmann, Anette Friedrichs, Georg Mn Behrens, et al.
Mayo Clinic Proceedings|March 18, 2026
Impact of COVID-19 vaccination on post-COVID syndrome across clinical definitions and phenotypes: a prospective multicenter cohort studyTanja Kraus, Hendrik Napierala, Anne Schrimpf, et al.
Critical Reviews in Microbiology|January 11, 2019
Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope<sup>®</sup>Danila Seidel, Arne Meißner, Michaela Lackner, et al.
International Journal of Antimicrobial Agents|December 20, 2016
Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA StudyPhilipp Koehler, Axel Hamprecht, Oliver Bader, et al.
Infection|July 31, 2025
Performance of whole blood interferon-γ release assays in SARS-CoV-2 and tuberculosis is age dependentTobias Rothoeft, Anna Teresa Hoffmann, Christoph Maier, et al.
European Journal of Neurology|August 19, 2021
Neurological symptoms and complications in predominantly hospitalized COVID-19 patients: Results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS)Nina N Kleineberg, Samuel Knauss, Eileen Gülke, et al.
Eclinicalmedicine|September 1, 2023
Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trialFlorent Malard, Michael Loschi, Anne Huynh, et al.
Frontiers in Medicine|July 3, 2023
Fighting Post-COVID and ME/CFS - development of curative therapiesCarmen Scheibenbogen, Judith Theresia Bellmann-Strobl, Cornelia Heindrich, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2019
Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn)Jon Salmanton-García, Danila Seidel, Philipp Koehler, et al.
Pageof 23